Literature DB >> 31046551

Cognitive Implications of Ototoxicity in Pediatric Patients With Embryonal Brain Tumors.

Traci W Olivier1, Johnnie K Bass1, Jason M Ashford1, Rebecca Beaulieu1, Sarah M Scott1, Jane E Schreiber2, Shawna Palmer1, Donald J Mabbott3, Michelle A Swain4, Melanie Bonner5, Robyn Boyle6, Mary Lynn Chapeiski7, Karen D Evankovich7, Carol L Armstrong2, Sarah J Knight8, Shengjie Wu1, Arzu Onar-Thomas1, Amar Gajjar1, Heather M Conklin1.   

Abstract

PURPOSE: Sensorineural hearing loss (SNHL) is associated with intellectual and academic declines in children treated for embryonal brain tumors. This study expands upon existing research by examining core neurocognitive processes that may result in reading difficulties in children with treatment-related ototoxicity. PATIENTS AND METHODS: Prospectively gathered, serial, neuropsychological and audiology data for 260 children and young adults age 3 to 21 years (mean, 9.15 years) enrolled in a multisite research and treatment protocol, which included surgery, risk-adapted craniospinal irradiation (average risk, n = 186; high risk, n = 74), and chemotherapy, were analyzed using linear mixed models. Participants were assessed at baseline and up to 5 years after diagnosis and grouped according to degree of SNHL. Included were 196 children with intact hearing or mild to moderate SNHL (Chang grade 0, 1a, 1b, or 2a) and 64 children with severe SNHL (Chang grade 2b or greater). Performance on eight neurocognitive variables targeting reading outcomes (eg, phonemics, fluency, comprehension) and contributory cognitive processes (eg, working memory, processing speed) was analyzed.
RESULTS: Participants with severe SNHL performed significantly worse on all variables compared with children with normal or mild to moderate SNHL (P ≤ .05), except for tasks assessing awareness of sounds and working memory. Controlling for age at diagnosis and risk-adapted craniospinal irradiation dose, performance on the following four variables remained significantly lower for children with severe SNHL: phonemic skills, phonetic decoding, reading comprehension, and speed of information processing (P ≤ .05).
CONCLUSION: Children with severe SNHL exhibit greater reading difficulties over time. Specifically, they seem to struggle most with phonological skills and processing speed, which affect higher level skills such as reading comprehension.

Entities:  

Mesh:

Year:  2019        PMID: 31046551      PMCID: PMC6599406          DOI: 10.1200/JCO.18.01358

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  34 in total

Review 1.  Neurocognitive sequelae of childhood cancers and their treatment.

Authors:  Raymond K Mulhern; Robert W Butler
Journal:  Pediatr Rehabil       Date:  2004 Jan-Mar

2.  An improved methodology for modeling neurobehavioral late-effects of radiotherapy in pediatric brain tumors.

Authors:  M Douglas Ris; Patricia McDonough Ryan; Michael Lamba; John Brenemen; Kim Cecil; Paul Succop; William Ball
Journal:  Pediatr Blood Cancer       Date:  2005-05       Impact factor: 3.167

Review 3.  Platinum-induced hearing loss after treatment for childhood cancer.

Authors:  Jorrit W van As; Henk van den Berg; Elvira C van Dalen
Journal:  Cochrane Database Syst Rev       Date:  2016-08-03

4.  International consensus (ICON) on audiological assessment of hearing loss in children.

Authors:  A Farinetti; A Raji; H Wu; B Wanna; C Vincent
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2018-02-01       Impact factor: 2.080

5.  Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.

Authors:  M D Ris; R Packer; J Goldwein; D Jones-Wallace; J M Boyett
Journal:  J Clin Oncol       Date:  2001-08-01       Impact factor: 44.544

6.  Working memory performance among childhood brain tumor survivors.

Authors:  Heather M Conklin; Jason M Ashford; Robyn A Howarth; Thomas E Merchant; Robert J Ogg; Victor M Santana; Wilburn E Reddick; Shengjie Wu; Xiaoping Xiong
Journal:  J Int Neuropsychol Soc       Date:  2012-06-13       Impact factor: 2.892

7.  Feasibility and efficacy of a computer-based intervention aimed at preventing reading decoding deficits among children undergoing active treatment for medulloblastoma: results of a randomized trial.

Authors:  Shawna L Palmer; Laurie Leigh; Susan C Ellison; Arzu Onar-Thomas; Shengjie Wu; Ibrahim Qaddoumi; Gregory T Armstrong; Karen Wright; Cynthia Wetmore; Alberto Broniscer; Amar Gajjar
Journal:  J Pediatr Psychol       Date:  2013-12-25

8.  Hearing loss and cognitive decline in older adults.

Authors:  Frank R Lin; Kristine Yaffe; Jin Xia; Qian-Li Xue; Tamara B Harris; Elizabeth Purchase-Helzner; Suzanne Satterfield; Hilsa N Ayonayon; Luigi Ferrucci; Eleanor M Simonsick
Journal:  JAMA Intern Med       Date:  2013-02-25       Impact factor: 21.873

9.  Intellectual Outcome in Molecular Subgroups of Medulloblastoma.

Authors:  Iska Moxon-Emre; Michael D Taylor; Eric Bouffet; Kristina Hardy; Cynthia J Campen; David Malkin; Cynthia Hawkins; Normand Laperriere; Vijay Ramaswamy; Ute Bartels; Nadia Scantlebury; Laura Janzen; Nicole Law; Karin S Walsh; Donald J Mabbott
Journal:  J Clin Oncol       Date:  2016-10-31       Impact factor: 44.544

10.  Hearing Loss in Patients Who Received Cranial Radiation Therapy for Childhood Cancer.

Authors:  Johnnie K Bass; Chia-Ho Hua; Jie Huang; Arzu Onar-Thomas; Kirsten K Ness; Skye Jones; Stephanie White; Shaum P Bhagat; Kay W Chang; Thomas E Merchant
Journal:  J Clin Oncol       Date:  2016-01-25       Impact factor: 44.544

View more
  12 in total

1.  Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.

Authors:  Johnnie K Bass; Wei Liu; Pia Banerjee; Tara M Brinkman; Daniel A Mulrooney; Amar Gajjar; Alberto S Pappo; Thomas E Merchant; Gregory T Armstrong; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson; Kevin R Krull
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

2.  Intellectual changes after radiation for children with brain tumors: which brain structures are most important?

Authors:  Derek S Tsang; Laurence Kim; Zhihui Amy Liu; Laura Janzen; Mohammad Khandwala; Eric Bouffet; Normand Laperriere; Hitesh Dama; Dana Keilty; Tim Craig; Vijay Ramaswamy; David C Hodgson; Donald Mabbott
Journal:  Neuro Oncol       Date:  2021-03-25       Impact factor: 12.300

3.  Effect of sensorineural hearing loss on neurocognitive and adaptive functioning in survivors of pediatric embryonal brain tumor.

Authors:  Andrew M Heitzer; Alexandra M Villagran; Kimberly Raghubar; Austin L Brown; Miranda L Camet; M Douglas Ris; Jenny H Hanning; M Fatih Okcu; Arnold C Paulino; Murali Chintagumpala; Lisa S Kahalley
Journal:  J Neurooncol       Date:  2019-11-28       Impact factor: 4.130

Review 4.  Prevention of cisplatin-induced ototoxicity in children and adolescents with cancer: a clinical practice guideline.

Authors:  David R Freyer; Penelope R Brock; Kay W Chang; L Lee Dupuis; Sidnei Epelman; Kristin Knight; Denise Mills; Robert Phillips; Emma Potter; Demie Risby; Philippa Simpkin; Michael Sullivan; Sandra Cabral; Paula D Robinson; Lillian Sung
Journal:  Lancet Child Adolesc Health       Date:  2019-12-19

5.  Longitudinal associations between exposure to anesthesia and neurocognitive functioning in pediatric medulloblastoma.

Authors:  M Partanen; D L Anghelescu; L Hall; J E Schreiber; M Rossi; A Gajjar; L M Jacola
Journal:  Eur J Cancer       Date:  2021-03-17       Impact factor: 9.162

Review 6.  Cognitive Risk in Survivors of Pediatric Brain Tumors.

Authors:  Ade Oyefiade; Iris Paltin; Cinzia R De Luca; Kristina K Hardy; David R Grosshans; Murali Chintagumpala; Donald J Mabbott; Lisa S Kahalley
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

Review 7.  Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer.

Authors:  Lisa M Jacola; Marita Partanen; Jurgen Lemiere; Melissa M Hudson; Sophie Thomas
Journal:  J Clin Oncol       Date:  2021-04-22       Impact factor: 50.717

8.  Clinical and genetic risk factors for radiation-associated ototoxicity: A report from the Childhood Cancer Survivor Study and the St. Jude Lifetime Cohort.

Authors:  Matthew R Trendowski; Jessica L Baedke; Yadav Sapkota; Lois B Travis; Xindi Zhang; Omar El Charif; Heather E Wheeler; Wendy M Leisenring; Leslie L Robison; Melissa M Hudson; Lindsay M Morton; Kevin C Oeffinger; Rebecca M Howell; Gregory T Armstrong; Smita Bhatia; M Eileen Dolan
Journal:  Cancer       Date:  2021-07-19       Impact factor: 6.860

Review 9.  Pathology, diagnostics, and classification of medulloblastoma.

Authors:  Brent A Orr
Journal:  Brain Pathol       Date:  2020-05       Impact factor: 6.508

10.  Child development at 6 years after maternal cancer diagnosis and treatment during pregnancy.

Authors:  Tineke Vandenbroucke; Magali Verheecke; Mathilde van Gerwen; Kristel Van Calsteren; Michael J Halaska; Monica Fumagalli; Robert Fruscio; Amarendra Gandhi; Margreet Veening; Lieven Lagae; Petronella B Ottevanger; Jens-Uwe Voigt; Jorine de Haan; Mina M Gziri; Charlotte Maggen; Luc Mertens; Gunnar Naulaers; Laurence Claes; Frédéric Amant
Journal:  Eur J Cancer       Date:  2020-08-25       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.